• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 M 通过腺病毒肝脏过表达调控鞘氨醇 1-磷酸动态平衡与肝脏损伤

Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.

机构信息

Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

出版信息

Atherosclerosis. 2013 Jul;229(1):102-9. doi: 10.1016/j.atherosclerosis.2013.04.024. Epub 2013 Apr 28.

DOI:10.1016/j.atherosclerosis.2013.04.024
PMID:23664237
Abstract

OBJECTIVES

Sphingosine 1-phosphate (S1P) is a vasoprotective lipid mediator that is mainly carried on HDL in the circulation and several anti-atherosclerotic properties of HDL is considered to be ascribed to S1P. Since S1P riding on HDL was recently shown to bind to apolipoprotein M (apoM), which is derived from liver, we analyzed the possible involvement of liver in S1P metabolism.

METHODS AND RESULTS

Using adenoviruses, we overexpressed apoM in HepG2 cells and mice livers and found that both the medium/plasma and cell/liver S1P contents increased. Among lipoprotein subclasses, S1P contents increased mainly in HDL fractions. On the other hand, hepatectomy resulted in the reduction of plasma S1P levels in mice. The incubation of S1P in the conditional medium of apoM-overexpressing HepG2 cells interfered with S1P degradation. Furthermore, adenoviral hepatic overexpression of apoM resulted in increase in the S1P level of plasma but not of blood cells, while combination of hepatic apoM overexpression and intraperitoneal administration of C₁₇-sphingosine resulted in the increase in the C₁₇-S1P level both in livers and in plasma, but again not in blood cells.

CONCLUSIONS

Livers are involved in S1P dynamism, and it was suggested that apoM, produced from livers, increases circulating plasma S1P by augmenting the S1P output from livers and modifies extracellular S1P metabolism.

摘要

目的

鞘氨醇 1-磷酸(S1P)是一种血管保护性脂质介质,主要在循环中与高密度脂蛋白(HDL)结合,而 HDL 的几种抗动脉粥样硬化特性被认为归因于 S1P。由于最近发现 S1P 与载脂蛋白 M(apoM)结合,而 apoM 来源于肝脏,因此我们分析了肝脏在 S1P 代谢中的可能作用。

方法和结果

我们使用腺病毒在 HepG2 细胞和小鼠肝脏中过表达 apoM,发现细胞/肝脏和中/血浆 S1P 含量均增加。在脂蛋白亚类中,S1P 含量主要在 HDL 部分增加。另一方面,肝切除术导致小鼠血浆 S1P 水平降低。将 S1P 孵育在 apoM 过表达 HepG2 细胞的条件培养基中会干扰 S1P 的降解。此外,apoM 在肝脏中的过表达会增加血浆中的 S1P 水平,但不会增加血细胞中的 S1P 水平,而同时进行肝脏 apoM 过表达和腹腔内给予 C₁₇-鞘氨醇会导致肝脏和血浆中的 C₁₇-S1P 水平增加,但不会增加血细胞中的 C₁₇-S1P 水平。

结论

肝脏参与 S1P 动力学,提示肝脏产生的 apoM 通过增加肝脏的 S1P 输出和改变细胞外 S1P 代谢来增加循环血浆 S1P。

相似文献

1
Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.载脂蛋白 M 通过腺病毒肝脏过表达调控鞘氨醇 1-磷酸动态平衡与肝脏损伤
Atherosclerosis. 2013 Jul;229(1):102-9. doi: 10.1016/j.atherosclerosis.2013.04.024. Epub 2013 Apr 28.
2
Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.肝载脂蛋白 M(apoM)过表达可刺激形成更大的 apoM/神经鞘氨醇 1-磷酸富含的血浆高密度脂蛋白。
J Biol Chem. 2014 Jan 31;289(5):2801-14. doi: 10.1074/jbc.M113.499913. Epub 2013 Dec 6.
3
Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions.胆固醇酯转运蛋白(CETP)在鞘氨醇-1-磷酸在脂蛋白间的转移及其功能调节中的作用。
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):506-514. doi: 10.1161/ATVBAHA.116.308692. Epub 2017 Jan 26.
4
HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.与高密度脂蛋白(HDL)相关的载脂蛋白M通过将1-磷酸鞘氨醇传递至血管内皮细胞上的1-磷酸鞘氨醇受体1(S1P1)和1-磷酸鞘氨醇受体3(S1P3)而具有抗细胞凋亡作用。
Lipids Health Dis. 2017 Feb 8;16(1):36. doi: 10.1186/s12944-017-0429-2.
5
LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate.低密度脂蛋白受体和载脂蛋白E参与了与载脂蛋白M相关的1-磷酸鞘氨醇的清除过程。
J Biol Chem. 2015 Jan 23;290(4):2477-88. doi: 10.1074/jbc.M114.596445. Epub 2014 Dec 12.
6
Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.载脂蛋白 M 和鞘氨醇-1-磷酸在遗传性高密度脂蛋白代谢异常患者中的血浆水平。
Atherosclerosis. 2011 Dec;219(2):855-63. doi: 10.1016/j.atherosclerosis.2011.08.049. Epub 2011 Sep 6.
7
High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.高密度脂蛋白相关载脂蛋白M通过将1-磷酸鞘氨醇传递至1-磷酸鞘氨醇受体1来限制内皮炎症。
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):118-129. doi: 10.1161/ATVBAHA.116.308435. Epub 2016 Nov 22.
8
Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate.鞘氨醇-1-磷酸载体载脂蛋白M对胰岛素分泌的诱导作用。
Biochim Biophys Acta. 2014 Sep;1841(9):1217-26. doi: 10.1016/j.bbalip.2014.05.002. Epub 2014 May 9.
9
Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity.肝 PPARγ 活性对载脂蛋白 M 和鞘氨醇 1-磷酸代谢的调节。
Biochem J. 2018 Jun 21;475(12):2009-2024. doi: 10.1042/BCJ20180052.
10
Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.鞘氨醇-1-磷酸及其载体载脂蛋白M在人类脓毒症和狒狒大肠杆菌脓毒症中的作用
J Cell Mol Med. 2016 Jun;20(6):1170-81. doi: 10.1111/jcmm.12831. Epub 2016 Mar 17.

引用本文的文献

1
C-reactive protein modulates lipid mediators in a pro-inflammatory direction.C反应蛋白在促炎方向上调节脂质介质。
J Inflamm (Lond). 2025 Aug 12;22(1):32. doi: 10.1186/s12950-025-00459-5.
2
ApoM maintains cellular homeostasis between mitophagy and apoptosis by affecting the stability of Nnt mRNA through the Zic3-ApoM-Elavl2-Nnt axis during neural tube closure.在神经管闭合过程中,载脂蛋白M(ApoM)通过Zic3 - ApoM - Elavl2 - Nnt轴影响Nnt mRNA的稳定性,从而维持细胞自噬与凋亡之间的动态平衡。
Cell Death Dis. 2025 Jan 19;16(1):29. doi: 10.1038/s41419-025-07343-3.
3
Kidney derived apolipoprotein M and its role in acute kidney injury.
肾脏来源的载脂蛋白M及其在急性肾损伤中的作用。
Front Pharmacol. 2024 Jan 19;15:1328259. doi: 10.3389/fphar.2024.1328259. eCollection 2024.
4
Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids.肝细胞ABCA1缺乏与高密度脂蛋白鞘脂减少有关。
Front Physiol. 2023 Aug 4;14:1208719. doi: 10.3389/fphys.2023.1208719. eCollection 2023.
5
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate.鞘脂与动脉粥样硬化:神经酰胺和1-磷酸鞘氨醇的双重作用
Antioxidants (Basel). 2023 Jan 6;12(1):143. doi: 10.3390/antiox12010143.
6
Apolipoprotein D modulates lipid mediators and osteopontin in an anti-inflammatory direction.载脂蛋白 D 向抗炎方向调节脂质介质和骨桥蛋白。
Inflamm Res. 2023 Feb;72(2):263-280. doi: 10.1007/s00011-022-01679-8. Epub 2022 Dec 19.
7
Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH.鞘氨醇激酶 1 在 NASH 小鼠模型中介导纤维化的性别二态性。
Mol Metab. 2022 Aug;62:101523. doi: 10.1016/j.molmet.2022.101523. Epub 2022 Jun 6.
8
HDL and Endothelial Function.高密度脂蛋白与血管内皮功能。
Adv Exp Med Biol. 2022;1377:27-47. doi: 10.1007/978-981-19-1592-5_3.
9
Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.脂质在脂蛋白上的运输的分子机制。
Adv Exp Med Biol. 2022;1372:57-65. doi: 10.1007/978-981-19-0394-6_5.
10
Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus.2 型糖尿病患者脂蛋白及脂蛋白缺乏部分中神经酰胺和神经鞘氨醇分布的差异。
J Atheroscler Thromb. 2022 Dec 1;29(12):1727-1758. doi: 10.5551/jat.63249. Epub 2022 Jan 27.